CheMo4METPANC: Combination Chemotherapy ( gemcitabine and nabpaclitaxel), chemokine (C-X-C) Motif receptor 4 inhibitor (motixafortide), and immune checkpoint blockade (cemiplimab) in METastatic treatment-naive PANCreatic adenocarcinoma

CANCER RESEARCH(2024)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要